ArticleClinicoEconomics and outcomes research : CEOR2019
Cost-benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand.
Chaicharn Deerochanawong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.